Literature DB >> 23026023

Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.

Fang Wang1, Wenzhuo He, Huijuan Qiu, Xi Wang, Guifang Guo, Xuxian Chen, Yuming Rong, Feifei Zhou, Chenxi Yin, Zhongyu Yuan, Liangping Xia.   

Abstract

BACKGROUND: The lymph node ratio (LNR) classification has shown superiority to pN staging (the number of positive lymph nodes) in breast cancers, but it has not been examined according to whether sufficient lymph nodes have been dissected.
METHODS: All Chinese patients with luminal A breast cancer with positive lymph nodes seen at Sun Yat-sen University Cancer Center between 1995 and 2009 were enrolled. Disease-free survival (DFS) and overall survival (OS) were the endpoints, and the patients were further classified into 2 groups according to whether ≤ 10 or > 10 lymph nodes were dissected.
RESULTS: For the whole group, the OS curves of the pN stages overlapped, whereas they were separated in the LNR survival curves. LNR was an independent prognostic factor for OS and DFS, whereas the pN stage was not. In the ≤ 10 lymph nodes dissected group, both OS and DFS curves were clearly separated in the pN staging but overlapped in the LNR classification. In the > 10 lymph nodes dissected group, LNR showed no overlap in the OS curves and was an independent prognostic factor of OS and DFS when compared with pN staging.
CONCLUSION: In Chinese patients with luminal A breast cancer, LNR classification and the pN stage show different superiority as prognostic predictors according to whether > 10 or < 10 lymph nodes are dissected.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026023     DOI: 10.1016/j.clbc.2012.07.009

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  5 in total

1.  Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center.

Authors:  Yen-Lin Chen; Cheng-Yi Wang; Chin-Chia Wu; Moon-Sing Lee; Shih-Kai Hung; Wei-Chou Chen; Chih-Yao Hsu; Chia-Wen Hsu; Chih-Yuan Huang; Yu-Chieh Su; Ching-Chih Lee
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-29       Impact factor: 4.553

2.  Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients.

Authors:  San-Gang Wu; Zhen-Yu He; Qun Li; Jia-Yuan Sun; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Xun-Xing Guan
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

3.  Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?

Authors:  Upali W Jayasinghe; Nirmala Pathmanathan; Elisabeth Elder; John Boyages
Journal:  Springerplus       Date:  2015-03-11

4.  Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System.

Authors:  Zhe Wang; Wei Chong; Huikun Zhang; Xiaoli Liu; Yawen Zhao; Zhifang Guo; Li Fu; Yongjie Ma; Feng Gu
Journal:  Front Cell Dev Biol       Date:  2022-04-04

5.  Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients.

Authors:  Atilla Soran; Tolga Ozmen; Arsalan Salamat; Gürsel Soybir; Ronald Johnson
Journal:  Eur J Breast Health       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.